Yahoo Finance Results
- Thomson Reuters StreetEvents via Yahoo FinanceNov 07 12:36 PM
Now already this quarter, we have earned 2 milestone payments from AstraZeneca totaling nearly $30 million for advancing 2 different programs. We are on track to easily meet our guidance ...
- Motley Fool via Yahoo FinanceNov 06 22:48 PM
Stanley T. Crooke -- Chairman of the Board & Chief Executive Officer The other thing that's sort of been forgotten, but it's tremendously impressive to me is that it's not just in the NURTURE ...
AstraZeneca Pharmaceuticals LP, a biopharmaceutical company, focuses on the discovery, development, and commercialization of prescription medicines to customers worldwide. It offers medicines ...
Drugs Associated with AstraZeneca. AstraZeneca manufactures, markets and/or distributes more than 44 drugs in the United States. Medications listed here may also be marketed under different names in different countries.
About AstraZeneca Pharmaceuticals LP. AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
AstraZeneca Pharmaceuticals LP is the United States division of AstraZeneca, a global biopharmaceutical research and manufacturing company that produces a portfolio of brand-name pharmaceuticals, including Prilosec, Nexium, and Crestor.
About Astrazeneca Pharmaceuticals LP AstraZeneca Pharmaceuticals (which does business as AstraZeneca US) can help with a full alphabet of ailments. The company, a subsidiary of global drugmaker AstraZeneca , is one of the largest pharma companies in the US.
When viewing a listing, consider the state advertising restrictions to which lawyers and law firms must adhere, as well as our West Legal Directory disclaimers.Some lawyers publish comparative information regarding the services that they provide which may be subject to specific comparative communications restrictions.
Docket activity of federal case PARR v. ASTRAZENECA PHARMACEUTICALS LP et al, case number 2:18-cv-16028, from New Jersey Court.